Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 27 | 2025 | 771 | 9.060 |
Why?
|
| Metformin | 4 | 2021 | 166 | 1.920 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 5 | 2024 | 625 | 1.470 |
Why?
|
| Obesity | 8 | 2025 | 2391 | 1.450 |
Why?
|
| Glucose | 2 | 2023 | 878 | 1.100 |
Why?
|
| Air Filters | 3 | 2025 | 3 | 1.090 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2019 | 89 | 1.090 |
Why?
|
| Particulate Matter | 3 | 2024 | 79 | 1.080 |
Why?
|
| Adrenal Cortex Hormones | 3 | 2025 | 340 | 1.070 |
Why?
|
| Environmental Exposure | 3 | 2022 | 234 | 1.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2021 | 1408 | 0.990 |
Why?
|
| Pulmonary Emphysema | 3 | 2024 | 93 | 0.990 |
Why?
|
| Air Pollution, Indoor | 5 | 2025 | 34 | 0.860 |
Why?
|
| Wildfires | 1 | 2024 | 2 | 0.850 |
Why?
|
| Safety-net Providers | 1 | 2025 | 70 | 0.850 |
Why?
|
| Lung Diseases | 2 | 2025 | 408 | 0.750 |
Why?
|
| Triglycerides | 2 | 2023 | 617 | 0.730 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2024 | 215 | 0.720 |
Why?
|
| Schools | 2 | 2022 | 236 | 0.710 |
Why?
|
| Cardiovascular Diseases | 2 | 2025 | 2092 | 0.690 |
Why?
|
| Bronchitis, Chronic | 1 | 2021 | 19 | 0.690 |
Why?
|
| Diabetes Mellitus | 2 | 2019 | 921 | 0.690 |
Why?
|
| Hypoglycemic Agents | 1 | 2024 | 482 | 0.660 |
Why?
|
| Forced Expiratory Volume | 1 | 2021 | 173 | 0.650 |
Why?
|
| Urban Population | 2 | 2019 | 244 | 0.640 |
Why?
|
| Insulin Resistance | 2 | 2025 | 697 | 0.620 |
Why?
|
| Smokers | 1 | 2019 | 44 | 0.590 |
Why?
|
| Veterans | 3 | 2025 | 1757 | 0.590 |
Why?
|
| Family Characteristics | 1 | 2019 | 93 | 0.580 |
Why?
|
| Pediatric Obesity | 4 | 2025 | 415 | 0.570 |
Why?
|
| Humans | 45 | 2025 | 132061 | 0.570 |
Why?
|
| Smoking | 2 | 2020 | 938 | 0.550 |
Why?
|
| Metabolic Syndrome | 1 | 2021 | 364 | 0.540 |
Why?
|
| United States | 10 | 2025 | 11658 | 0.520 |
Why?
|
| Cohort Studies | 7 | 2025 | 5164 | 0.480 |
Why?
|
| Adult | 14 | 2025 | 31568 | 0.470 |
Why?
|
| Air Pollutants | 3 | 2022 | 114 | 0.460 |
Why?
|
| Anti-Asthmatic Agents | 2 | 2025 | 118 | 0.410 |
Why?
|
| Middle Aged | 14 | 2025 | 28964 | 0.410 |
Why?
|
| Female | 24 | 2025 | 70712 | 0.400 |
Why?
|
| Male | 21 | 2025 | 64922 | 0.400 |
Why?
|
| Primary Health Care | 1 | 2019 | 791 | 0.390 |
Why?
|
| Comorbidity | 3 | 2025 | 1609 | 0.380 |
Why?
|
| Air Pollution | 2 | 2022 | 74 | 0.340 |
Why?
|
| Overweight | 3 | 2025 | 383 | 0.340 |
Why?
|
| Spirometry | 2 | 2022 | 75 | 0.340 |
Why?
|
| Respiratory Function Tests | 2 | 2021 | 211 | 0.330 |
Why?
|
| Aged | 10 | 2025 | 21406 | 0.330 |
Why?
|
| Respiratory Sounds | 2 | 2022 | 71 | 0.330 |
Why?
|
| Retrospective Studies | 10 | 2025 | 17419 | 0.330 |
Why?
|
| Hospitalization | 4 | 2025 | 1898 | 0.300 |
Why?
|
| Disease Progression | 5 | 2025 | 2224 | 0.300 |
Why?
|
| Nutrition Surveys | 2 | 2021 | 314 | 0.290 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 3990 | 0.290 |
Why?
|
| Oximetry | 3 | 2023 | 178 | 0.270 |
Why?
|
| Administration, Inhalation | 2 | 2025 | 190 | 0.270 |
Why?
|
| Risk Factors | 4 | 2023 | 10941 | 0.260 |
Why?
|
| Blood Glucose | 2 | 2021 | 1123 | 0.250 |
Why?
|
| Biomarkers | 4 | 2025 | 3406 | 0.240 |
Why?
|
| Child | 11 | 2025 | 25789 | 0.230 |
Why?
|
| Hydrocortisone | 1 | 2025 | 226 | 0.220 |
Why?
|
| Eosinophils | 1 | 2025 | 122 | 0.220 |
Why?
|
| Treatment Outcome | 5 | 2025 | 13028 | 0.210 |
Why?
|
| Shock, Septic | 1 | 2025 | 154 | 0.210 |
Why?
|
| Lymphadenopathy | 1 | 2024 | 31 | 0.210 |
Why?
|
| Smoke | 1 | 2024 | 66 | 0.210 |
Why?
|
| Emphysema | 1 | 2024 | 67 | 0.200 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2025 | 305 | 0.200 |
Why?
|
| Neck Pain | 1 | 2022 | 19 | 0.190 |
Why?
|
| Achievement | 1 | 2022 | 31 | 0.190 |
Why?
|
| Baltimore | 2 | 2019 | 18 | 0.190 |
Why?
|
| Sarcoidosis | 1 | 2022 | 57 | 0.190 |
Why?
|
| Oxygen | 2 | 2023 | 572 | 0.190 |
Why?
|
| Medication Adherence | 1 | 2025 | 328 | 0.180 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2025 | 488 | 0.180 |
Why?
|
| Blast Injuries | 1 | 2022 | 61 | 0.180 |
Why?
|
| Dyspnea | 2 | 2022 | 159 | 0.180 |
Why?
|
| Single-Cell Analysis | 1 | 2025 | 347 | 0.180 |
Why?
|
| Protective Agents | 1 | 2021 | 36 | 0.180 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2025 | 688 | 0.180 |
Why?
|
| Acute Disease | 1 | 2024 | 1160 | 0.180 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2021 | 20 | 0.170 |
Why?
|
| Cost-Benefit Analysis | 1 | 2024 | 576 | 0.170 |
Why?
|
| Information Systems | 1 | 2021 | 35 | 0.170 |
Why?
|
| Intensive Care Units | 2 | 2025 | 523 | 0.170 |
Why?
|
| Symptom Assessment | 1 | 2021 | 111 | 0.170 |
Why?
|
| Positive-Pressure Respiration, Intrinsic | 1 | 2020 | 2 | 0.170 |
Why?
|
| Emigrants and Immigrants | 1 | 2022 | 158 | 0.170 |
Why?
|
| Students | 1 | 2022 | 263 | 0.160 |
Why?
|
| Lung | 3 | 2025 | 1559 | 0.160 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2019 | 18 | 0.150 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2023 | 234 | 0.150 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2019 | 75 | 0.140 |
Why?
|
| Propensity Score | 1 | 2019 | 257 | 0.140 |
Why?
|
| Registries | 1 | 2025 | 1572 | 0.140 |
Why?
|
| Transcriptome | 1 | 2025 | 1125 | 0.140 |
Why?
|
| Cough | 1 | 2018 | 97 | 0.140 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 504 | 0.130 |
Why?
|
| Texas | 1 | 2025 | 3629 | 0.120 |
Why?
|
| Emergency Service, Hospital | 2 | 2025 | 1170 | 0.120 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 1454 | 0.120 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 3761 | 0.120 |
Why?
|
| Referral and Consultation | 1 | 2019 | 568 | 0.110 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2022 | 648 | 0.110 |
Why?
|
| Adolescent | 4 | 2025 | 20562 | 0.110 |
Why?
|
| Severity of Illness Index | 2 | 2025 | 3091 | 0.110 |
Why?
|
| Inflammation | 1 | 2022 | 1517 | 0.110 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 5409 | 0.110 |
Why?
|
| Databases, Factual | 1 | 2019 | 1227 | 0.110 |
Why?
|
| Child, Preschool | 3 | 2019 | 14751 | 0.110 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 7102 | 0.110 |
Why?
|
| Quality of Life | 1 | 2024 | 2137 | 0.100 |
Why?
|
| Electronic Health Records | 1 | 2021 | 800 | 0.100 |
Why?
|
| Body Mass Index | 1 | 2018 | 1694 | 0.090 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 3014 | 0.090 |
Why?
|
| Tidal Volume | 2 | 2022 | 41 | 0.090 |
Why?
|
| Prognosis | 1 | 2018 | 5009 | 0.070 |
Why?
|
| Hospital Mortality | 2 | 2025 | 1057 | 0.070 |
Why?
|
| Gene Expression Profiling | 2 | 2025 | 1882 | 0.070 |
Why?
|
| Leukocyte Count | 1 | 2025 | 251 | 0.060 |
Why?
|
| Vasoconstrictor Agents | 1 | 2025 | 141 | 0.060 |
Why?
|
| Young Adult | 1 | 2019 | 9957 | 0.050 |
Why?
|
| Renal Replacement Therapy | 1 | 2025 | 158 | 0.050 |
Why?
|
| Eosinophilia | 1 | 2025 | 106 | 0.050 |
Why?
|
| Drug Administration Schedule | 1 | 2025 | 749 | 0.050 |
Why?
|
| Snoring | 1 | 2023 | 18 | 0.050 |
Why?
|
| Afghanistan | 1 | 2022 | 16 | 0.050 |
Why?
|
| Iraq | 1 | 2022 | 11 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2025 | 1672 | 0.050 |
Why?
|
| Environmental Monitoring | 1 | 2021 | 90 | 0.040 |
Why?
|
| Hypoxia | 1 | 2022 | 258 | 0.040 |
Why?
|
| Cigarette Smoking | 1 | 2021 | 80 | 0.040 |
Why?
|
| Peru | 1 | 2020 | 56 | 0.040 |
Why?
|
| Minority Groups | 1 | 2022 | 249 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2022 | 6567 | 0.040 |
Why?
|
| Proteomics | 1 | 2024 | 596 | 0.040 |
Why?
|
| Seasons | 1 | 2021 | 327 | 0.040 |
Why?
|
| Length of Stay | 1 | 2025 | 1379 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2022 | 991 | 0.040 |
Why?
|
| Poverty | 1 | 2021 | 446 | 0.030 |
Why?
|
| Intubation, Intratracheal | 1 | 2020 | 289 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2025 | 2172 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 1183 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2025 | 4703 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 4757 | 0.020 |
Why?
|
| Mice | 1 | 2021 | 18507 | 0.010 |
Why?
|
| Animals | 1 | 2021 | 34882 | 0.010 |
Why?
|